Biomarkers Used to Identify andor Quantify Exposure to Boron

Boron in blood and urine can be used as an indicator of exposure to boron. Normal dietary concentrations of boron in the blood of humans range from 0 to 1.25 mg/mL in children and infants (Fisher and Freimuth 1958; O'Sullivan and Taylor 1983). Boron blood levels (reported as borate) of 20-150 mg/mL have been associated with adverse systemic effects in infants who ingested boric acid in infant formula (Wong et al. 1964). Boron concentrations, expressed as borate, reported in fatal cases vary from 200 to 1,600 mg/mL in infants (Wong et al. 1964). In adults, a serum boron level (as boric acid) of 2,320 mug/mL was not associated with significant toxicity (Linden et al. 1986).

Urinary excretion levels can also be useful indicators of elevated total body burden of boron. Concentrations of boron in the normal population range from 0.07 to 0.15 mg/100 mL (Vignec and

Concentrations of boron in the normal population range from 0.07 to 0.15 mg/100 mL (Vignec and Ellis 1954) and 0.004 to 0.66 mg/100mL (Imbus et al. 1963). In one infant, the urine contained 13.9 mg boron/L as borax or 1.38 mg boron/mL of boric acid following ingestion of a borax and honey mixture over a period of 12 weeks (Gordon et al. 1973). Virtually complete urinary excretion was indicated by the recovery of 93.9% (over a 96-hour collection period) of a boric acid solution ingested by three human volunteers (Jansen et al. 1984a).

Neurological, dermal, gastrointestinal, liver, and kidney effects in humans have been associated with exposure to boron. Studies in animals have demonstrated gonadal injury. Various clinical and biochemical tests exist that may provide useful information on exposure. However, similar effects are caused by a variety of other substances and are, therefore, not specific for boron exposure.

0 0

Post a comment